Pennington Generation Cohort
ConditionObesity Prevention
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeNot listed
SponsorPennington Biomedical Research Center
About this trial
The Pennington Generation Cohort is an observational study comprised of Louisiana families. Families will be assessed at baseline for a variety of traits and behaviors, and then followed up over time to try to understand the role of lifestyle and the environment on the risk of developing obesity and other health outcomes.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Children, adolescents, and young adults (birth through age 24 years) and their nuclear family members* and adults age 25+ who are expectant parents or are trying to conceive
Self-reported resident of Louisiana
Ability to understand instructions and complete all study procedures
Able to provide informed consent (adults aged over 18 years)
Disqualifiers
Discretion of the Medical Monitor or Principal Investigator
Trial population
Adults of child-bearing age who are planning to become pregnant, expectant parents, as well as children, adolescents, and young adults and their nuclear family members will be recruited.
Trial design
Design model
Cohort
Time perspective
Prospective
Treatments tested in this trial
Not listed
Trial groups
No trial groups listed
Trial outcomes
Primary outcomes
1
Obesity
The development of obesity, defined using BMI z-scores during childhood, and BMI during adulthood.
Time frame
From enrollment up to 20 years of follow-up.Secondary outcomes
1
Weight change
Change in body weight.
Time frame
From enrollment up to 20 years of follow-up.2
Mortality
Data from the Pennington Generation Prospective Cohort will be prospectively linked to the National Death Index for the ascertainment of mortality.
Time frame
From enrollment up to 20 years of follow-up..3
Cancer incidence
Data from the Pennington Generation Prospective Cohort will be prospectively linked to the Louisiana Tumor Registry for the ascertainment of incident cancer.
Time frame
From enrollment up to 20 years of follow-up..Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov